Rapid Evolution to Blast Crisis Associated with a Q252H ABL1 Kinase Domain Mutation in e19a2 BCR-ABL1 Chronic Myeloid Leukaemia
A minority of chronic myeloid leukaemia (CML) patients express variant transcripts of which the e19a2 BCR-ABL1 fusion is the most common. Instances of tyrosine kinase inhibitor (TKI) resistance in e19a2 BCR-ABL1 CML patients have rarely been reported. A case of e19a2 BCR-ABL1 CML is described in who...
Main Authors: | Sarah L. McCarron, Karena Maher, Johanna Kelly, Mary F. Ryan, Stephen E. Langabeer |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2013/490740 |
Similar Items
-
Molecular analysis of the BCR-ABL translocation in chronic myeloid leukaemia
by: Zhang, Ji Guang
Published: (1997) -
No Benefit of BCR-ABL1 Screening in Polycythemia
by: STEPHEN E. LANGABEER
Published: (2016-07-01) -
BCR-ABL positive and negative haemopoietic cells in chronic myeloid leukaemia
by: Grand, Frances Hector
Published: (1999) -
Successful treatment with ABL tyrosine kinase inhibitor for patients with acute myeloid leukemia with BCR-ABL1
by: Asako Takeuchi, et al.
Published: (2021-01-01) -
Chronic Myeloid Leukemia with e19a2 BCR-ABL1 Transcripts and Marked Thrombocytosis: The Role of Molecular Monitoring
by: Stephen E. Langabeer, et al.
Published: (2012-01-01)